Enhanced care by generalists for functional somatic symptoms and disorders in primary care
Información
- DOI:
- https://doi.org/10.1002/14651858.CD008142Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 07 octubre 2009see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Trastornos mentales comunes
- Copyright:
-
- Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Marianne Rosendal and Chris Burton wrote the protocol draft, other authors contributed with critical feedback and discussions of methods. All authors accepted the final version of the protocol.
Sources of support
Internal sources
-
Research Unit for General Practice, Århus, Denmark.
-
Community Health Sciences, General Practice Section, University of Edinburgh, UK.
-
Department of General Practice, EMGO Instituut (VU), Amsterdam, Netherlands.
-
The Research Clinic for Functional Disorders and Psychosomatics, Århus University Hospital, Denmark.
-
Department of Medicine and Regenstrief Institute, Indiana University, USA.
-
School of Molecular & Clinical Medicine, University of Edinburgh, UK.
-
Department of Biostatistics, Institute of Public Health, University of Århus, Denmark.
-
Department of Psychiatry, University of Nottingham, UK.
External sources
-
No sources of support supplied
Declarations of interest
Marianne Rosendal has been actively participating in the evaluation of RCTs cited in this review and is currently involved in the development of treatment guidelines for Danish primary care. The working hours spent on this Cochrane review has been part of standard employment at the Research Unit for General Practice. No other conflicts of interest known.
Chris Burton: no conflicts of interest known.
Nettie Blankenstein has been the primary researcher in one of the RCTs on reattribution cited in this review. Currently, she is involved in the development of a multi‐disciplinary treatment guideline on somatoform symptoms and disorders for Dutch primary and secondary health care. She has contributed to the development of a training course for general practitioners on cognitive‐behavioural treatment for functional symptoms. Her contribution to this Cochrane review is part of her employment at the department of general practice of the VU university medical center. No further conflicts of interest known.
Per Fink has been involved in RCTs on treatment of medically unexplained symptoms in primary care and is currently participating in the development of treatment guidelines for Danish primary care. No other conflicts of interest known.
Kurt Kroenke has had research support from Eli Lilly and Pfizer and honoraria from them plus Forest in relation to research in depression. No other conflicts of interest known.
Michael Sharpe: no conflicts of interest known.
Morten Frydenberg: no conflicts of interest known.
Richard Morriss has been the chief investigator of one of the RCTs cited in this review as well as a previous non‐randomised treatment trial. No other conflicts of interest known.
Version history
| Published | Title | Stage | Authors | Version |
| 2013 Oct 18 | Enhanced care by generalists for functional somatic symptoms and disorders in primary care | Review | Marianne Rosendal, Annette H Blankenstein, Richard Morriss, Per Fink, Michael Sharpe, Christopher Burton | |
| 2009 Oct 07 | Enhanced care by generalists for functional somatic symptoms and disorders in primary care | Protocol | Marianne Rosendal, Chris Burton, Annette H Blankenstein, Per Fink, Kurt Kroenke, Michael Sharpe, Morten Frydenberg, Richard Morriss | |
Keywords
MeSH
Medical Subject Headings (MeSH) Keywords
Medical Subject Headings Check Words
Adult; Humans;
PICO
| Type of instrument | Name | references |
| Questionnaire | Abridged criteria | |
|
| PHQ‐15 | |
|
| SCL‐som | |
|
| Whiteley‐7 | |
| Interview | SCAN | |
|
| DIS | |
|
| CIDI | |
| Health care use | Frequent attendance | |
| The table may be supplemented by specific instruments for functional somatic syndromes The final review will also include a table of names and classification terms | ||
| Rubric | Reviewer 1 | Reviewer 2 | Conclusion | |
| Author name |
|
|
| |
| Title of paper |
|
|
| |
| Name of study |
|
|
| |
| Personal notes (e.g. name of disorder used) |
|
|
| |
| Reason for exclusion |
|
|
| |
| Study characteristics |
|
|
| |
|
| Assessment of methods (table 2) |
|
|
|
|
| Setting of the study (the primary care organisation) |
|
|
|
|
| Level of randomisation and measures of clustering |
|
|
|
|
| The risk of contamination (control patients receiving intervention unintentional or vice versa) |
|
|
|
|
| Doctor characteristics and sampling (previous training, years in practice, GP age) |
|
|
|
|
| Patient characteristics (inclusion, exclusion, ethnicity, diagnosis, symptom duration, psychiatric co‐morbidity) and sampling (population screening, waiting room screening, GP assessment, diagnostic instruments used) |
|
|
|
|
| Intervention* in active group |
|
|
|
|
| Intervention in control group |
|
|
|
|
| Outcome measure and instrument for assessment (primary outcome, secondary outcome, subgroups) |
|
|
|
|
| Length of maximum follow‐up |
|
|
|
|
| Results |
|
|
|
| * Interventions
| ||||
